Archives

Drug Discovery, Clues from the Clinic

Dr. John LaMattina, former R&D President at Pfizer, has declared new drug development to be “stochastic” – and for good reason. Only one drug in nine succeeds through the long, costly process of clinical trials.  For cancer, only one drug in twenty makes it to market. These numbers echo the relative success of “drug targets”…Continue Reading…